FORT LEE, N.J., June 13, 2012 /PRNewswire/ -- Herborium
Group, Inc. (OTC-PINK: HBRM) www.herborium.com has issued an update
on the proposed acquisition Term Sheet received from China based "China Health Resource, Inc.", a
company that manufactures herbal ingredients for Traditional
Chinese Medicines (TCM) in China. The Proposal from China
Health Resource, Inc. includes proposals to merge China Resource,
Inc. into Herborium Group, with Herborium to be the surviving
public entity.
"Review of such Proposals involves detailed understanding of all
aspects of a transaction by our Board of Directors, Legal Counsel,
accounting experts along with guidance from our Investment Banker.
This process will continue for the coming weeks. Shareholders will
be provided with further information as appropriate," stated Dr.
Agnes P. Olszewski, Herborium's
Chairwoman and CEO.
About Herborium Group, Inc.
Herborium Group, Inc., a Botanical Therapeutics®
company, focuses on developing, licensing, and marketing
proprietary, botanical based medicinal products to consumers and
healthcare professionals. The Company uses clinical
validation to establish and maintain a differential advantage. The
company sales its products in the US and Europe. For more information, please visit
www.herborium.com and www.acnease.com.
One of our most important responsibilities is to communicate
with shareholders in an open and direct manner. Comments are
based on current management expectations, and are considered
"forward-looking statements," generally preceded by words such as
"plans," "expects," "believes," "anticipates," or "intends."
We cannot promise future returns. Our statements reflect our
best judgment at the time, and we disclaim any obligation to update
or alter forward-looking statements as the result of new
information or future events. The Company urges
investors to review the risks and uncertainties contained within
its filings with the OTC Markets and/or Securities and Exchange
Commission.
For more information on this Press Release please
inquire: Kinsley Street Investors Group.
732-513-6921 or write to:
investorsrelations@herborium.com
SOURCE Herborium Group, Inc.